These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 9453443)

  • 21. Synthesis of insulinlike growth factor binding proteins and of the acid-labile subunit in primary cultures of rat hepatocytes, of Kupffer cells, and in cocultures: regulation by insulin, insulinlike growth factor, and growth hormone.
    Scharf J; Ramadori G; Braulke T; Hartmann H
    Hepatology; 1996 Apr; 23(4):818-27. PubMed ID: 8666337
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Growth hormone, but not insulin-like growth factor I, induces a serum protease activity for insulin-like growth factor binding protein-3 in hypophysectomized rats in vivo.
    Rutishauser J; Schmid C; Hauri C; Froesch ER; Zapf J
    FEBS Lett; 1993 Nov; 334(1):23-6. PubMed ID: 7693512
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metabolic and therapeutic effects of insulin-like growth factor I.
    Froesch ER; Zenobi PD; Hussain M
    Horm Res; 1994; 42(1-2):66-71. PubMed ID: 7959637
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [IGF-I].
    Miyakoshi N
    Nihon Rinsho; 2004 Feb; 62 Suppl 2():68-72. PubMed ID: 15035098
    [No Abstract]   [Full Text] [Related]  

  • 25. Combined growth hormone (GH) and insulin-like growth factor-I (IGF-I) treatment is more effective than GH or IGF-I alone at enhancing recovery from neonatal malnutrition in rats.
    Zhao X; Donovan SM
    J Nutr; 1995 Nov; 125(11):2773-86. PubMed ID: 7472657
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Potassium depletion in hepatic cirrhosis. A reversible cause of impaired growth-hormone and insulin response to stimulation.
    Podolsky S; Zimmerman HJ; Burrows BA; Cardarelli JA; Pattavina CG
    N Engl J Med; 1973 Mar; 288(13):644-8. PubMed ID: 4687256
    [No Abstract]   [Full Text] [Related]  

  • 27. Nutritional support with amino acids in advanced cirrhosis: a few answers, a lot of questions.
    Marchesini G; Bianchi G
    Nutrition; 1999 Oct; 15(10):799-800. PubMed ID: 10501300
    [No Abstract]   [Full Text] [Related]  

  • 28. Complex pattern of insulin-like growth factor binding protein expression in primary rat osteoblast enriched cultures: regulation by prostaglandin E2, growth hormone, and the insulin-like growth factors.
    McCarthy TL; Casinghino S; Centrella M; Canalis E
    J Cell Physiol; 1994 Jul; 160(1):163-75. PubMed ID: 7517403
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Changes within the growth hormone/insulin-like growth factor I/IGF binding protein axis during critical illness.
    Mesotten D; Van den Berghe G
    Endocrinol Metab Clin North Am; 2006 Dec; 35(4):793-805, ix-x. PubMed ID: 17127147
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The insulin-like growth factor system and diabetes--an overview.
    Heald A; Stephens R; Gibson JM
    Diabet Med; 2006 Mar; 23 Suppl 1():19-24. PubMed ID: 16483261
    [No Abstract]   [Full Text] [Related]  

  • 31. Nocturnal nutritional supplementation improves total body protein status of patients with liver cirrhosis: a randomized 12-month trial.
    Plank LD; Gane EJ; Peng S; Muthu C; Mathur S; Gillanders L; McIlroy K; Donaghy AJ; McCall JL
    Hepatology; 2008 Aug; 48(2):557-66. PubMed ID: 18627001
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Short-term effect of recombinant human growth hormone in patients with alcoholic cirrhosis.
    Møller S; Becker U; Grønbaek M; Juul A; Winkler K; Skakkebaek NE
    J Hepatol; 1994 Nov; 21(5):710-7. PubMed ID: 7534320
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Functional role of insulin-like growth factor binding proteins.
    Ranke MB; Elmlinger M
    Horm Res; 1997; 48 Suppl 4():9-15. PubMed ID: 9350439
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulation of ovarian follicular growth by somatotropin and insulin-like growth factors in cattle.
    Lucy MC
    J Dairy Sci; 2000 Jul; 83(7):1635-47. PubMed ID: 10908067
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acquired growth hormone resistance.
    Ross RJ; Chew SL
    Eur J Endocrinol; 1995 Jun; 132(6):655-60. PubMed ID: 7788000
    [No Abstract]   [Full Text] [Related]  

  • 36. The effect of recombinant human insulin-like growth factor-I treatment on growth hormone secretion in two subjects with growth hormone insensitivity (Laron syndrome).
    Cotterill AM; Camacho-Hübner C; Holly JM; Savage MO
    Clin Endocrinol (Oxf); 1993 Jul; 39(1):119-22. PubMed ID: 7688671
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulation of the growth hormone receptor/binding protein, insulin-like growth factor ternary complex system in human cirrhosis.
    Donaghy AJ; Delhanty PJ; Ho KK; Williams R; Baxter RC
    J Hepatol; 2002 Jun; 36(6):751-8. PubMed ID: 12044524
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of insulin-like growth factor I (IGF-I) administrations on serum IGF binding proteins (IGFBPs) in patients with growth hormone deficiency.
    Hizuka N; Takano K; Asakawa-Yasumoto K; Fukuda I; Suzuki T; Demura H; Shimojoh C; Shizume K
    Adv Exp Med Biol; 1993; 343():301-9. PubMed ID: 7514343
    [No Abstract]   [Full Text] [Related]  

  • 39. Production of IGFBP-3 by connective tissue and endothelial cells.
    Schmid C; Schläpfer I; Waldvogel M; Peter M; Zapf J; Froesch ER
    Growth Regul; 1993 Mar; 3(1):65-7. PubMed ID: 7683535
    [No Abstract]   [Full Text] [Related]  

  • 40. Growth hormone binding protein in cirrhosis: normal or decreased?
    Møller S; Fisker S; Becker U; Henriksen JH
    J Hepatol; 2002 Nov; 37(5):702-3. PubMed ID: 12399243
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.